The quick answer: sermorelin has mixed, limited body-composition findings. The directly relevant evidence discussed here is a small study of older men, and it found no change in muscle mass after six weeks [4]. That same study is the main source on how fast sermorelin works.
The muscle study found no change in lean mass after six weeks
In 1997, researchers gave sermorelin to 11 healthy men aged 64 to 76, all with low IGF-1 to start. After six weeks, DEXA scans showed no change in muscle or fat. Weight, body mass index and waist-to-hip ratio didn't change either. Neither did muscle tissue under the microscope [4].
Some things did move. Night-time growth hormone release went up. Two of six strength measures improved: the upright row and the shoulder press. One endurance test, the abdominal crunch, improved too.
The catch: there was no comparison group. Strength can rise in six weeks just from repeating the tests. With 11 people and no placebo, nobody can say how much of that came from the drug.
| Claim | Evidence | Result | Strength of evidence |
|---|---|---|---|
| Increases muscle mass | Vittone 1997: 11 men, 6 weeks, no control group [4] | No change in DEXA lean mass | Low |
| Increases strength | Same study | 2 of 6 measures improved (upright row, shoulder press) | Low |
| Raises IGF-1 | Same study; Khorram 1997 tested a related molecule [5] | No change at 6 weeks; the related molecule raised it 28% by 4 weeks | Low |
| Reduces fat | Vittone 1997 | No change in DEXA fat | Low |
| Builds muscle alongside training | No supporting training trial in the cited evidence | Benefit not established | Uncertain |
Koutkia studied Geref in 31 men with HIV-associated lipodystrophy for 12 weeks. DXA lean mass changed by +2.0 lb (+0.9 kg) versus −0.7 lb (−0.3 kg); trunk fat by −0.9 lb (−0.4 kg) versus +0.4 lb (+0.2 kg). These were secondary endpoints, not strength outcomes [1].
A separate 19-person study of a modified Nle27 GHRH analog reported increased lean mass in men only and transient hyperlipidemia. It did not study identical sermorelin or demonstrate an athletic benefit [2].
More growth hormone doesn't automatically mean more muscle
Sermorelin raises growth hormone pulses. But IGF-1, which carries most of growth hormone's effects on tissue, didn't rise in the older men [4]. A hormone change alone would not establish increased muscle size, strength or function.
A related molecule did raise IGF-1. In 19 older adults, a version of the same peptide with one amino acid swapped lifted IGF-1 by 28% within four weeks [5]. That study measured immune cells, not muscle. So it tells you the hormone can move, not that muscle follows.
Related tesamorelin studies do not establish a sermorelin benefit
Tesamorelin, another growth-hormone-releasing hormone analog, has more data. In a pooled look at two trials of adults with HIV and belly fat, trunk muscle area grew slightly over 26 weeks compared with placebo [6]. The analysis only counted people whose deep belly fat fell by at least 8%. More on that drug is in our tesamorelin muscle guide.
Those are small numbers, under a tenth of a square inch each. And tesamorelin isn't sermorelin. It is an approved drug for a narrow HIV indication. Its approved labeling and separate compounding requirements do not establish a lawful equivalent of an advertised wellness preparation.
Tesamorelin also increased DXA lean mass by 3.7% in a 20-week randomized study of healthy older adults and adults with mild cognitive impairment, while reducing body fat by 7.4% without a weight change [3]. DXA lean mass is not a direct strength measurement. These results concern tesamorelin, not sermorelin, and do not establish an athletic benefit.
Resistance training is what trials show builds muscle; protein adds a little
The resistance-training review below studied adults who trained while taking protein or a comparator. A 2018 review pooled 49 randomized trials with 1,863 adults who lifted for at least six weeks. Adding protein on top increased fat-free mass gains by 0.66 lb (0.30 kg) and one-rep strength by 5.5 lb (2.49 kg) [7].
The protein benefit shrank with age and was larger in people who already trained. That's a modest, well-measured effect. The cited sermorelin evidence does not establish a comparable muscle benefit.
When to take sermorelin for muscle is your prescriber's call
Your prescriber sets when and how you take sermorelin. Timing tips online for muscle aren't based on a muscle study, because the cited studies do not establish a muscle-building timing schedule. If someone gives you a schedule "for gains", ask what trial it came from.
If body composition is your goal, start with what has data
If you want more muscle and less fat, training and protein have the strongest evidence. A prescriber can tell you whether a hormone treatment fits on top, and which labs to check first. The body composition shortlist covers programs built around that goal, and the hormones shortlist covers testosterone and other hormone care.
Many people ask about sermorelin while they're on a GLP-1, hoping to hold on to muscle. That question has its own answer in taking sermorelin with tirzepatide. If you still want to try sermorelin, our sermorelin cost guide shows what programs charge.
Ask what a prescriber would measure before you start
If muscle is the reason you're asking, say so at the intake. A good prescriber will want a baseline before anything ships. That makes it possible to tell later whether anything changed.
- Which labs will you check first? IGF-1 is the usual one for growth-hormone treatments.
- How will we measure muscle? A scale can't tell muscle from fat, so ask whether a body-composition scan is part of the plan.
- What result at follow-up would mean it's working, and what would mean we stop?
- Does anything in my health history make a growth-hormone treatment a poor fit?
Also be clear about what sermorelin is today. It's a compounded prescription, not a currently FDA-approved drug. The brand, Geref, lost its approvals in 2009 after the maker stopped selling it, and FDA said in 2013 that the withdrawal wasn't for safety or effectiveness reasons [8]. Compounded drugs aren't FDA-approved, and FDA doesn't check them for safety or quality before they're dispensed.
Your call from there. Training and protein are the parts with numbers behind them. Sermorelin is an open question for muscle, and right now the six-week study discussed here found no mass change.